Patients | Demographic information | Age | Dosage | Cmax (ng•mL−1) | Ctrough (ng•mL− 1) | CL/F (L•h− 1) | Vd (L) |
---|---|---|---|---|---|---|---|
Undergoing total hip replacement [17] | Caucasian | 27 ~ 93 | 10 mg qd | 124.6a | 9.1a | 7.3 | 49.1 |
Deep venous thrombosis [18] | Caucasian | 18 ~ 91 | 20 mg qd | 270 | 25.5 | 5.67 | 54.4 |
Non-valvular atrial fibrillation [19] | Caucasian | 51 ~ 92 | 20 mg qd | 290 | 32 | 6.1 | 79.7 |